Krka, d. d. (WSE:KRK)

Market Cap	26.10B
Revenue (ttm)	8.37B
Net Income (ttm)	1.62B
Shares Out	n/a
EPS (ttm)	52.70
PE Ratio	16.15
Forward PE	15.93
Dividend	35.03 (4.13%)
Ex-Dividend Date	Jul 22, 2025

Volume	16
Average Volume	277
Open	856.00
Previous Close	846.00
Day's Range	844.00 - 856.00
52-Week Range	570.00 - 900.00
Beta	0.49
RSI	53.64
Earnings Date	Jul 24, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR